AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-765693_ITM" title="Facts and information about New Migraine Tablet.">New Migraine Tablet.</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
New Migraine Tablet.
Zomig (zolmitriptan) has been approved as an orally ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- New Migraine Tablet.
- Magazine article from: Family Practice News May 15, 2001 700+ words
Zomig (zolmitriptan) has been approved as an orally disintegrating tablet for the treatment of acute migraine in adults.
- Latest Research to Stimulate New Migraine Treatment Options - Claim Leading...
- Press release article from: PR Newswire Europe September 21, 2004 700+ words
...avoid progression of the condition. With a similar call for new migraine treatments, lecturer and researcher at Oxford University...know the exact areas of the brain where pain is felt then new migraine therapies can be developed to target more accurately the...
- Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief...
- Press release article from: PR Newswire December 4, 2007 700+ words
...today plans to enter the over-the-counter market with a new migraine relief homeopathic nasal spray. The nasal spray is scheduled...formulations." "The development of the technology behind the new migraine product was actually quite serendipitous", added Hensley...
- Glaxo soon to introduce new migraine drug. (Glaxo Caribbean to market...
- Magazine article from: Caribbean Business Estrada, Edgar December 5, 1991 700+ words
Glaxo soon to introduce new migraine drug According to medical statistics, migraine affects one out of every eight adults. However, it not only affects the patient...
- Elan and UCB Announce Agreement to Co-Promote New Migraine Drug FROVA (TM);...
- Press release article from: PR Newswire March 28, 2002 700+ words
...pharmaceutical and chemical group ("UCB"), announced today that they have entered into an agreement to co-promote the new migraine drug FROVA (frovatriptan succinate) in the United States. Elan and UCB will launch FROVA in the second quarter of 2002...
- Orchard Park, N.Y.-Based Firm to Launch New Migraine Cooling Pads.
- Newspaper article from: Knight Ridder/Tribune Business News Linstedt, Sharon June 3, 1999 700+ words
...advertising effort. The Orchard Park-based company, which is owned by Rohto Pharmaceutical of Osaka, Japan, will debut its new Migraine Ice headache pads next week, via its largest product launch. Mentholatum's Director of New Products, Joni Sahhar, said...
- Press Release: Elan and UCB announce agreement to co-promote new migraine drug...
- News wire article from: Chemical Business Newsbase March 28, 2002 700+ words
Elan Corp plc and UCB Pharma Inc have entered into an agreement to co-promote the new migraine drug Frova (frovatriptan succinate) in the US. Elan and UCB Pharma will launch Frova in 2Q 2002. Under the terms of the co...
- New migraine treatment is tested.
- News wire article from: UPI NewsTrack September 28, 2006 700+ words
CHICAGO, Sept. 28 (UPI) -- Researchers at the Rush University Medical Center in Chicago are testing occipital nerve stimulation as a new treatment for migraine headaches. The medical specialists say the treatment involves implanting a neurostimulator to deliver electrical impulses to nerves under
- New migraine treatment has fewer side effects.
- News wire article from: Chemical Business Newsbase November 25, 2008 700+ words
A new treatment for migraine that is as effective as existing drugs but with fewer side effects will bring fresh hope to millions of sufferers, scientists said on 24 Nov 2008. Improved understanding of the mechanism that causes the brain to over-react to stimuli has led to the development of a drug
- New migraine drug rivals early promise of triptans: CGRP peptide...
- Magazine article from: Family Practice News Moon, Mary Ann May 15, 2004 700+ words
The first agent in a new class of antimigraine medications to become available for clinical testing proved safe and effective in a small pilot study--as effective as triptans were in their initial clinical studies. Researchers are evaluating this class of drugs--calcitonin gene-related peptide
Source: HighBeam Research, New Migraine Tablet.